From: Plasma Ephrin-A1 level in a cohort of diabetic retinopathy patients
non-DM (n = 19) | DM (n = 16) | DR (n = 20) | P | P Value 1 | P Value 2 | P Value 3 | |
---|---|---|---|---|---|---|---|
Age (years) | 60.53 ± 4.04 | 63.31 ± 4.97 | 60.25 ± 6.72 | 0.048 | 0.093 | 0.159 | 0.741 |
male/female | 11/8 | 8/8 | 11/9 | ||||
BMI (kg/m2) | 22.01 ± 2.25 | 24.48 ± 3.17 | 24.32 ± 3.66 | 0.032 | 0.068 | 1 | 0.072 |
FPG (mmol/l) | 5.57 ± 0.62 | 8.91 ± 3.04 | 8.16 ± 2.57 | <0.001 | <0.001 | > 0.05 | <0.001 |
HbA1c(%) | 5.33 ± 0.32 | 8.65 ± 2.56 | 8.22 ± 1.84 | <0.001 | <0.001 | > 0.05 | <0.001 |
VEGF165(pg/ml) | 34.79 ± 38.65 | 24.43 ± 17.33 | 40.91 ± 58.01 | 0.093 | |||
Ephrin-A1(ng/ml) | 0.27 ± 0.13 | 0.35 ± 0.34 | 3.63 ± 4.63 | <0.001 | > 0.05 | <0.001 | <0.001 |
Serum creatinine (μg/ml) | 54.32 ± 12.74 | 68.88 ± 34.04 | 70.10 ± 26.63 | 0.063 | |||
Total cholesterol (mmol/l) | 5.19 ± 1.09 | 5.41 ± 1.45 | 5.00 ± 1.00 | 0.064 | |||
Duration of DM (months) | 0 | 46 ± 18.5 | 118 ± 49 |